Homologous recombination plays a critical role in reductional segregation of chromosomes in meiosis. Meiotic recombination is initiated by the programmed induction of DNA double strand breaks (DSBs) and involves a mechanism related to recombinational repair of DSBs in mitotic cells. Meiotic recombination is subject to unique regulatory processes that promote recombination between homologous chromatids rather than sister chromatids and also regulate the frequency of crossover type recombination events to ensure all homologous chromosome pairs engage in at least one such event. The central step of recombination is homologous strand invasion and exchange. Budding yeast and many other organisms including humans have a specialized meiotic recombinase, Dmc1, that catalyzes the central step of meiotic recombination which involves DNA sequence homology searching that culminates in DNA strand exchange to form regions of hybrid DNA that connect recombining partners. A different strand exchange protein, Rad51, catalyzes the central step of mitotic recombination. Dmc1 has a unique set of meiosis-specific accessory proteins, but is also regulated by mitotic recombination proteins, including the mitotic recombinase Rad51. Rad51 is converted from an enzyme in mitosis into to a Dmc1 accessory protein during meiosis. Our group studies the molecular mechanism through which Dmc1 promotes meiotic recombination. We seek to understand how Dmc1?s activity is regulated by each of its accessory proteins. This goal is achieved by combining a wide range of advanced experimental approaches. Of particular importance is our group?s unique effort to biochemically reconstitute the recombination process using purified components. To complement our biochemical studies, we were first to develop the tools and methods required to study the architecture and dynamics of meiotic recombinosomes using super-resolution light microscopy. Our group also employs molecular genetic techniques that allow detection of broken and branched DNA recombination intermediates, as well as the protein-protein interactions that occur during the recombination process. We seek to combine these approaches to uncover important mechanistic features of the recombination process including the regulatory mechanisms that control it.

Public Health Relevance

Our group studies the mechanism of meiotic recombination. Defects in meiotic recombination cause chromosome segregation errors during formation of eggs and sperm that lead to birth defects and miscarriage. In addition, meiotic recombination is closely related to mitotic recombinational DNA repair, a process that prevents cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Unknown (R35)
Project #
5R35GM134942-02
Application #
10086100
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Keane-Myers, Andrea
Project Start
2020-02-01
Project End
2025-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Chicago
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637